Showing 101 - 120 results of 506 for search '"type 1 diabetes"', query time: 0.10s Refine Results
  1. 101
  2. 102
  3. 103

    An Uncommon Presentation of Hamman’s Syndrome in an Adolescent With Acute Diabetic Ketoacidosis and Newly Diagnosed Type 1 Diabetes by Daliya George, Malini Rajandran, Habib Bhurawala, Gary M. Leong

    Published 2024-01-01
    “…This case report discusses the occurrence of Hamman’s syndrome in an 11-year-old adolescent male newly diagnosed with type 1 diabetes mellitus (T1DM) and presenting with severe DKA. …”
    Get full text
    Article
  4. 104
  5. 105
  6. 106

    Unveiling Silent Atherosclerosis in Type 1 Diabetes: The Role of Glycoprotein and Lipoprotein Lipidomics, and Cardiac Autonomic Neuropathy by Sara de Lope Quiñones, Manuel Luque-Ramírez, Antonio Carlos Michael Fernández, Alejandra Quintero Tobar, Jhonatan Quiñones-Silva, María Ángeles Martínez García, María Insenser Nieto, Beatriz Dorado Avendaño, Héctor F. Escobar-Morreale, Lía Nattero-Chávez

    Published 2025-01-01
    “…<b>Introduction:</b> This study aimed to evaluate whether glycoprotein and lipoprotein lipidomics profiles could enhance a clinical predictive model for carotid subclinical atherosclerosis in patients with type 1 diabetes (T1D). Additionally, we assessed the influence of cardiac autonomic neuropathy (CAN) on these predictive models. …”
    Get full text
    Article
  7. 107

    Exacerbation of Glycoprotein VI-Dependent Platelet Responses in a Rhesus Monkey Model of Type 1 Diabetes by J. F. Arthur, Y. Shen, Y. Chen, J. Qiao, R. Ni, Y. Lu, R. K. Andrews, E. E. Gardiner, J. Cheng

    Published 2013-01-01
    “…In this study, we used a nonhuman primate model of Type 1 diabetes to measure early downstream signalling events following engagement of the major platelet collagen receptor, glycoprotein (GP)VI. …”
    Get full text
    Article
  8. 108
  9. 109
  10. 110
  11. 111
  12. 112

    Experience with a Self-Management Education Program for Adolescents with Type 1 Diabetes: A Qualitative Study by Marília Costa Flora, Luísa Barros, Maria Isabel Dias da Costa Malheiro

    Published 2025-01-01
    “…This study examined participants’ perspectives on a type 1 diabetes self-management education program. <b>Methods</b>: Focus group interviews were conducted with 32 adolescents with type 1 diabetes who participated in the program and six expert patients. …”
    Get full text
    Article
  13. 113

    Serological markers of exocrine pancreatic function are differentially informative for distinguishing individuals progressing to type 1 diabetes by Desmond Schatz, Laura Jacobsen, Todd M Brusko, Michael J Haller, Mark Atkinson, MacKenzie D Williams, Catherine Ramsey Grace, Amanda L Posgai, Kieran M McGrail, Maigan A Brusko, Rhonda Bacher, Clive H Wasserfall

    Published 2025-01-01
    “…Introduction Altered serum levels of growth hormones, adipokines, and exocrine pancreas enzymes have been individually linked with type 1 diabetes (T1D). We collectively evaluated seven such biomarkers, combined with islet autoantibodies (AAb) and genetic risk score (GRS2), for their utility in predicting AAb/T1D status.Research design and methods Cross-sectional serum samples (n=154 T1D, n=56 1AAb+, n=77 ≥2AAb+, n=256 AAb−) were assessed for IGF1, IGF2, adiponectin, leptin, amylase, lipase, and trypsinogen (n=543, age range 2.7–30.0 years) using random forest modeling.Results GRS2, age, lipase, trypsinogen, and AAb against ZnT8, GAD65, and insulin were the most informative markers. …”
    Get full text
    Article
  14. 114

    We Are on the Verge of Breakthrough Cures for Type 1 Diabetes, but Who Are the 2 Million Americans Who Have It? by Rebecca Smith, Samara Eisenberg, Aaron Turner-Phifer, Jacqueline LeGrand, Sarah Pincus, Yousra Omer, Fei Wang, Bruce Pyenson

    Published 2024-11-01
    “…**Background:** Two million Americans have type 1 diabetes (T1DM). Innovative treatments have standardized insulin delivery and improved outcomes for patients, but patients’ access to such technologies depends on social determinants of health, including insurance coverage, proper diagnosis, and appropriate patient supports. …”
    Get full text
    Article
  15. 115

    A Shared Path: Co-occurrence and Clinical Implications of Celiac Disease and Type 1 Diabetes Mellitus by Wojciech Florczak, Joanna Śnieżna, Jakub Dziewic, Karol Dzwonnik, Wiktoria Domino, Urszula Zelik, Gabriela Trestka, Maria Przygoda, Jagienka Włodyka, Kamila Stępień, Sabina Adamczyk

    Published 2025-01-01
    “… Introduction:  Celiac disease (CeD) and Type 1 diabetes mellitus (T1DM) are autoimmune diseases that sometimes co-occur in genetically predisposed people. …”
    Get full text
    Article
  16. 116

    Glucagon-like peptide-1 receptor agonists and type 1 diabetes: a potential game changer? by Ortal Resnick, Fernando Bril, Fernando Bril, Giovanna Beauchamp

    Published 2025-01-01
    “…This mini review explores the increasing prevalence of obesity in type 1 diabetes (T1D) and the challenges patients face in achieving optimal glycemic control with current treatments. …”
    Get full text
    Article
  17. 117

    Strategies to reduce hyperglycemia-related anxiety in elite athletes with type 1 diabetes: A qualitative analysis. by Alexandra Katz, Aidan Shulkin, Marc-André Fortier, Jane E Yardley, Jessica Kichler, Asmaa Housni, Meryem K Talbo, Rémi Rabasa-Lhoret, Anne-Sophie Brazeau

    Published 2025-01-01
    “…<h4>Objective</h4>Managing blood glucose levels is challenging for elite athletes with type 1 diabetes (T1D) as competition can cause unpredictable fluctuations. …”
    Get full text
    Article
  18. 118

    DPP-4 Inhibitors as Treatments for Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis by Qixian Wang, Min Long, Hua Qu, Rufei Shen, Rui Zhang, Jing Xu, Xin Xiong, Hui Wang, Hongting Zheng

    Published 2018-01-01
    “…Several clinical studies have reported the application of dipeptidyl peptidase-4 (DPP-4) inhibitors as treatments for type 1 diabetes mellitus (T1DM). This study aims to review the outcomes of these existing studies and to discuss the therapeutic effects of DPP-4 inhibitors on T1DM. …”
    Get full text
    Article
  19. 119

    Identification of Psychological Factors Associated with Adherence to Self-Care Behaviors amongst Patients with Type 1 Diabetes by Dácil Alvarado-Martel, M. Ángeles Ruiz Fernández, Maribel Cuadrado Vigaray, Armando Carrillo, Mauro Boronat, Ana Expósito Montesdeoca, Ana M. Wägner

    Published 2019-01-01
    “…To explore the factors involved in adherence to self-care behaviors in patients with type 1 diabetes. Materials and Methods. Patients with type 1 diabetes (age range: 14-71 years) were invited to participate at seven Spanish hospitals. …”
    Get full text
    Article
  20. 120

    High Risk of Early Cataracts in Young Type 1 Diabetes Group: A Nationwide Cohort Study by Wen-Li Lu, Po-Chih Shen, Chen-Hao Lee, Yu-Tsun Su, Li-Min Chen

    Published 2020-01-01
    “…Chronic hyperglycemia in type 1 diabetes (T1D) patients results in ocular problems over time, but only a few studies emphasized on cataracts. …”
    Get full text
    Article